Global Nuclear Imaging Equipment Market by Type (Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Hybrid Imaging Systems (PET/CT, PET/MRI)), by Application (Oncology, Cardiology, Neurology, Orthopedics, Others), by End-Use Industry (Hospitals, Diagnostic Centers, Research & Academic Institutions) and By Region: Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Nuclear Imaging Equipment Market was valued at USD 5.4 Billion in 2024-e and will surpass USD 9.8 Billion by 2030; growing at a CAGR of 10.6% during 2025 - 2030.

The nuclear imaging equipment market plays a vital role in the healthcare industry, offering advanced diagnostic tools for a wide range of medical conditions. These imaging systems use radioactive substances to generate detailed images of internal structures and functions, helping physicians diagnose and treat various diseases. Nuclear imaging techniques, such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), have become integral in diagnosing conditions like cancer, heart disease, and neurological disorders. The increasing demand for early-stage diagnosis, coupled with technological advancements in imaging techniques, has significantly contributed to the growth of this market.

The market for nuclear imaging equipment is expected to expand further due to rising incidences of chronic diseases, advancements in hybrid imaging systems that combine PET/CT and PET/MRI, and growing healthcare infrastructure investments globally. Furthermore, the integration of artificial intelligence (AI) and machine learning into imaging systems is improving the accuracy and efficiency of diagnosis, further fueling market growth. This growing shift towards precision medicine and personalized treatment is anticipated to keep the nuclear imaging equipment market on a robust growth trajectory.

Positron Emission Tomography (PET) Is Largest Technology Due to Its Accuracy and Comprehensive Diagnosis

Positron Emission Tomography (PET) is the largest technology segment in the nuclear imaging equipment market, owing to its high sensitivity and precision in diagnosing various types of cancers, heart diseases, and neurological conditions. PET imaging provides detailed, three-dimensional images of metabolic processes in the body, making it one of the most effective tools for detecting abnormalities at the cellular level. It plays a crucial role in oncology, enabling early detection of tumors, assessment of treatment efficacy, and monitoring of disease progression.

The significant growth of the PET market is fueled by advancements in PET scanners, which provide clearer and more accurate images, enhancing diagnosis and treatment planning. The ability of PET to detect early-stage cancers and other complex diseases is a key factor driving its widespread adoption in hospitals and diagnostic centers. As healthcare providers increasingly prioritize early diagnosis and personalized treatment plans, PET imaging technology continues to lead the market in terms of usage and adoption.

Oncology Is Largest Application Due to Growing Cancer Incidence and Early Detection Focus

Oncology is the largest application segment in the nuclear imaging equipment market, driven by the rising global incidence of cancer and the increasing emphasis on early detection and treatment. Nuclear imaging, particularly PET, is widely used in oncology for tumor detection, staging, and monitoring the effectiveness of treatments. The ability to identify cancer at early stages, when treatment options are more effective, is a key advantage that nuclear imaging offers, particularly in cancers such as lung, breast, and colorectal cancer.

As cancer rates continue to rise globally, the demand for nuclear imaging equipment in oncology is expected to remain strong. Additionally, advancements in imaging technology and the increasing availability of hybrid imaging systems, which combine the benefits of PET with other imaging modalities like CT and MRI, are improving diagnostic accuracy and patient outcomes. The oncology segment is expected to maintain its dominance in the market as healthcare systems continue to prioritize cancer care and early diagnosis.

Hospitals Are Largest End-Use Industry Due to High Patient Volume and Diagnostic Demand

Hospitals are the largest end-use industry for nuclear imaging equipment, driven by the high volume of patients requiring advanced diagnostic services. Hospitals offer a broad range of medical specialties and are often the primary centers for cancer treatment, cardiology, and neurology, all of which require nuclear imaging technologies. The availability of state-of-the-art imaging equipment in hospitals is critical for providing accurate and timely diagnoses, improving treatment outcomes, and optimizing patient care.

With the growing need for advanced diagnostic imaging in hospitals, particularly in the fields of oncology, cardiology, and neurology, the demand for nuclear imaging equipment is projected to grow steadily. Additionally, the growing number of hospital-based outpatient imaging centers is contributing to the increased adoption of nuclear imaging systems, further establishing hospitals as the dominant end-use industry in this market.

North America Region Is Largest Due to Advanced Healthcare Infrastructure and Technological Advancements

North America is the largest region in the nuclear imaging equipment market, primarily driven by the advanced healthcare infrastructure, high healthcare spending, and rapid adoption of cutting-edge imaging technologies. The U.S. and Canada are home to numerous world-leading hospitals, research institutions, and diagnostic centers, all of which utilize nuclear imaging systems for accurate diagnostics. The presence of key market players and a strong regulatory environment further supports the growth of the market in this region.

North America also benefits from substantial investments in research and development in medical imaging technologies, as well as the increasing focus on precision medicine and early-stage diagnosis. The widespread availability of advanced nuclear imaging equipment in hospitals and diagnostic centers across the region is expected to maintain North America’s leadership in the global market. As healthcare providers continue to adopt new technologies for improved diagnosis and treatment planning, the region is set to remain the largest market for nuclear imaging equipment.

Competitive Landscape and Key Players

The nuclear imaging equipment market is competitive, with several prominent companies leading the industry by offering innovative imaging systems. Key players in the market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Ltd. These companies have established a strong presence in the market by consistently advancing imaging technologies, offering a range of nuclear imaging solutions such as PET, SPECT, and hybrid imaging systems.

The competitive landscape is characterized by significant investments in research and development, with companies focusing on enhancing the capabilities of their imaging systems. The adoption of hybrid imaging technologies, such as PET/CT and PET/MRI, is a major trend in the market, as these systems provide more comprehensive and accurate diagnostics. Partnerships, collaborations, and acquisitions are common strategies employed by leading players to expand their product portfolios and enhance their market position. With continuous advancements in imaging technology, the competitive dynamics in the nuclear imaging equipment market will remain strong, with companies striving to meet the growing demand for high-quality, accurate diagnostic solutions.

Recent Developments:

• Siemens Healthineers unveiled a new PET/CT scanner that enhances the accuracy of cancer detection and treatment monitoring by offering high-resolution imaging and reduced scan time.
• GE Healthcare received FDA approval for its latest SPECT imaging system, designed to improve cardiovascular imaging capabilities for accurate disease diagnosis.
• Philips Healthcare introduced a new hybrid imaging system that combines PET and MRI, enabling precise cancer detection and better treatment planning.
• Canon Medical Systems Corporation announced a partnership with a leading hospital network to integrate advanced nuclear imaging systems into its diagnostic imaging department.
• Medtronic launched a new portable nuclear imaging device aimed at improving the accessibility of molecular imaging in remote or underserved regions.

List of Leading Companies:

• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems Corporation
• Hitachi Medical Corporation
• Medtronic
• Toshiba Medical Systems Corporation
• Shanghai United Imaging Healthcare Co., Ltd.
• Spectrum Dynamics Medical
• Neusoft Medical Systems Co., Ltd.
• Best Medical International
• United Imaging Healthcare Co., Ltd.
• Carestream Health
• Mirada Medical
• Nuvia Medical

Report Scope: